Ovarian Cancer
Ovarian Carcinoma
Female, 64 years
Patient Internal ID 517462092
ICD-10 code
C56 Malignant Neoplasm of Ovary
Diagnosis (Incl. Metastases/Stage) and Year
March 2014
Ovarian Carcinoma pT2aN0M0 R0 G2 Stage II. In July 2019, disease recurrence and progression with Abdominal Metastasis was diagnosed (G3).
Previous Treatment
Surgery (Hysterectomy with Omentectomy), Chemotherapy (Carboplatin), Chemotherapy (Paclitaxel/Carboplatin), Chemotherapy (Carboplatin/Gemcitabine).
Prognosis and Survival Expectation
The average relative 5-year survival rate for those diagnosed with Distant Spread Ovarian Cancer is about 31%. The median survival of Metastatic Ovarian Cancer is 24.7 months (Swedish Cancer Registry).
Treatment Provided
Autologous DCV and CIK (12 doses) over a period of 18 months. Additionally, the patient received Umbilical Cord Blood Derived NK Cells (3 doses).
Patient Survival/Condition and Year
Date of Review: 17/02/2024
The patient has survived for over 8 years since the diagnosis and 3 years after the recurrence and progression of the disease. It can be concluded that the addition of Immunotherapy, alongside Surgery and Chemotherapy, has extended patient survival by an estimate of 13 months.
